Subtype
Meningeal Neoplasm
CI-CAN-00001210Explore in graph →
Non-malignant111 active trials2 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001210Explore in graph →
Clinical trials
275 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04298541 | Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC | withdrawn | Phase 2 | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT06012929 | A Study of ONC201 for Refractory Meningioma | withdrawn | Phase 2 | 0 | University of NebraskaOTHER | 0 | Jan 26, 2026 | clinicaltrials |
| NCT04315246 |
| 177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma) |
| withdrawn |
| Phase 1 / Phase 2 |
| 0 |
| Y-mAbs TherapeuticsINDUSTRY |
| 2 |
| Jul 15, 2022 |
| clinicaltrials |
| NCT03013387 | Dosimetry Guided PRRT With 90Y-DOTATOC | withdrawn | Phase 2 | 0 | Sue O'DorisioOTHER | 0 | Aug 25, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Aug 31, 2026source: clinicaltrials